{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:41:21Z","timestamp":1791301281090,"version":"4.1.0"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int Forum Allergy Rhinol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Temperature\u2010controlled radiofrequency (TCRF) neurolysis of the posterior nasal nerve (PNN) area for the treatment of chronic rhinitis was previously reported as superior to a sham\u2010control procedure at 3\u00a0months postprocedure in a randomized controlled trial (RCT). The primary endpoint was a responder rate of \u226530% improvement (decrease) for 24\u2010hour reflective total nasal symptom score (rTNSS) compared with baseline. Herein, 12\u2010month outcomes after active treatment are reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective, multicenter, patient\u2010blinded RCT, patients in the index active treatment arm were unblinded at 3\u00a0months and followed through 12\u00a0months. At 3\u00a0months, eligible patients from the sham\u2010control arm of the study were invited to crossover to active treatment. Eligibility criteria included rTNSS \u22656, with moderate\u2010severe rhinorrhea and mild\u2010severe congestion. The TCRF stylus was applied bilaterally to nonoverlapping areas in the region of the PNN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients in the index active treatment arm (n = 77) had a mean baseline rTNSS of 8.3 (95% confidence interval [CI], 7.9\u20108.7). At 12\u00a0months, the responder rate was 80.6% (n = 67) (95% CI, 69.1%\u201089.2%). At 12 months, the mean change in rTNSS was \u22124.8 (95% CI, \u22125.5 to \u22124.1; <jats:italic>p\u00a0<\/jats:italic>&lt;\u00a00.001), a 57.8% improvement. The available initial rTNSS\u2010based outcomes in the crossover active treatment arm (<jats:italic>n<\/jats:italic>\u00a0=\u00a027) were following the same course as the index treatment arm. No serious adverse events and 8 adverse events related to the device\/procedure were reported in the trial to date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>TCRF neurolysis of the PNN area is safe and the symptom burden improvement that was superior to a sham procedure at 3 months was sustained through 12\u00a0months.<\/jats:p><\/jats:sec>","DOI":"10.1002\/alr.23047","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T18:38:56Z","timestamp":1655491136000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Temperature\u2010controlled radiofrequency neurolysis for treatment of chronic rhinitis: 12\u2010month outcomes after treatment in a randomized controlled trial"],"prefix":"10.1002","volume":"13","author":[{"given":"Masayoshi","family":"Takashima","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2010Head &amp; Neck Surgery Houston Methodist Hospital  Houston TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Pablo","family":"Stolovitzky","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Emory University School of Medicine  Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall A.","family":"Ow","sequence":"additional","affiliation":[{"name":"Sacramento Ear Nose and Throat Medical and Surgical Group  Roseville CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Silvers","sequence":"additional","affiliation":[{"name":"Madison ENT &amp; Facial Plastic Surgery  New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim B.","family":"Bikhazi","sequence":"additional","affiliation":[{"name":"The Ogden Clinic  Ogden UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Johnson","sequence":"additional","affiliation":[{"name":"ENT and Allergy Associates of Florida  Plantation FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/2473974\ufffd;211041124"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/19458924211033400"},{"key":"e_1_2_6_4_1","unstructured":"GlacyJ PutnamK GodfreyS et\u00a0al.AHRQ comparative effectiveness reviews. Report No. 13\u2010EHC098\u2010EF.Agencyfor Healthcare Research and Quality (US);2013."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.02.006"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28301"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22868"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.13.030190.000355"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6895.1000168"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-010-0093-3"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0636-3"},{"key":"e_1_2_6_12_1","first-page":"203","article-title":"The effect of gelfoam impregnated with botulinum toxin on allergic rhinitis","volume":"31","author":"Zand V","year":"2019","journal-title":"Iran J Otorhinolaryngol"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.09.013"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016480801935525"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1907862"}],"container-title":["International Forum of Allergy &amp; Rhinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alr.23047","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/alr.23047","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alr.23047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T08:43:56Z","timestamp":1692434636000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/alr.23047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1002\/alr.23047"],"URL":"https:\/\/doi.org\/10.1002\/alr.23047","archive":["Portico"],"relation":{},"ISSN":["2042-6976","2042-6984"],"issn-type":[{"value":"2042-6976","type":"print"},{"value":"2042-6984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"2022-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}